1.Practice of cervical cytology in China and overseas.
Chinese Journal of Pathology 2008;37(9):581-583
2.Evaluation of Self-collected Pad Sampling for the Detection of HPV In Cervicovaginal Secretion.
Seong Rim KIM ; Sang Yong SONG ; Dae Shick KIM ; Jung Won LEE ; Chang Soo PARK ; Duk Soo BAE ; Hyen Ji LEE ; Kyung Tae KIM ; Oh Joong KWON ; Eun Seop SONG ; Hee Jae JOO ; Gheungwhan AHN
Korean Journal of Pathology 2004;38(4):258-264
BACKGROUND: Self-collection of secretion samples for HPV testing is a feasible alternative method for women who would decline to participate in population based cervical cancer programs. The purpose of this study was to determine the sensitivity and specificity of self-sampling for HPV in determining high grade squamous intraepithelial lesion (HSIL) using the pad, and we also wished to compare the results from samples collected by women themselves and those results from samples collected by physicians. METHODS: Fifty patients voluntarily participated in the sensitivity and specificity study at the university hospitals and 290 volunteers participated in the agreement study at local clinics. DNA was extracted and amplified using HPV L1 consensus primers for the direct sequencing of the pad samples. RESULTS: For the detection of HSIL, self-collected pad sampling showed good sensitivity (75.0%) and excellent specificity (100%). Two hundreds eighty-six samples from the pads and concurrent physicians?samples showed the agreement at 98.6% with the Kappa, 0.9622 (p=0.0000). CONCLUSIONS: A self-sampling method using the pad for the detection of HPV DNA is suggested to be an efficient method to access many women for screening easily, rapidly and conveniently. Testing the pad method? utility for a country- or large area-based mass screening study will be necessary in the future.
Consensus
;
DNA
;
DNA Probes, HPV
;
Female
;
Hospitals, University
;
Humans
;
Mass Screening
;
Sensitivity and Specificity
;
Uterine Cervical Neoplasms
;
Volunteers
3.Primary Squamous Cell Carcinoma of the Upper Genital Tract: Utility of p16INK4a Expression and HPV DNA Status in its Differential Diagnosis from Extended Cervical Squamous Cell Carcinoma.
Su Hyun YOO ; Eun Mi SON ; Chang Okh SUNG ; Kyu Rae KIM
Korean Journal of Pathology 2013;47(6):549-556
BACKGROUND: Primary squamous cell carcinoma (SCC) of the upper genital tract, including the endometrium, fallopian tubes, and ovaries, is extremely rare. It must be distinguished from the mucosal extension of primary cervical SCC because determination of the primary tumor site is important for tumor staging. However, patients with SCC of the fallopian tubes or ovarian surface have often undergone prior hysterectomy with inadequate examination of the cervix, making it difficult to determine the primary site. METHODS: We compared histologic findings, p16INK4a expression, and human papillomavirus (HPV) DNA status in four patients with primary SCC of the upper genital tract and five patients with primary cervical SCC extending to the mucosa of the upper genital tract. RESULTS: All five SCCs of cervical origin showed strong expression of p16INK4a, whereas all four SCCs of the upper genital tract were negative, although one showed weak focal staining. Three of the five cervical SCCs were positive for HPV16 DNA, whereas all four primary SCCs of the upper genital tract were negative for HPV DNA. CONCLUSIONS: Although a thorough histological examination is important, immunonegativity for p16INK4a and negative for HPV DNA may be useful adjuncts in determining primary SCCs of the upper genital tract.
Carcinoma, Squamous Cell*
;
Cervix Uteri
;
Diagnosis, Differential*
;
DNA Probes, HPV
;
DNA*
;
Endometrium
;
Fallopian Tubes
;
Female
;
Genes, p16
;
Humans
;
Hysterectomy
;
Mucous Membrane
;
Neoplasm Staging
;
Ovary
4.Development and clinical application of male human papillomavirus genotyping by membrane DNA chip.
Yu-Ji JIN ; Li-Jie YUE ; Lin TAO ; Fang-Mei DENG ; De-Fa LI ; Wen-Shan HE ; Jie LIU ; Jian XIANG ; Hong CAI ; Qian-Qian TU ; Min HONG
National Journal of Andrology 2008;14(2):106-109
OBJECTIVETo develop a new method for the detection of male human papillomavirus (HPV) genotypes and to investigate its clinical application value.
METHODSWith computer assistance and based on the classical common primers MY09/11, modified PGMY09/11 with 23 HPV subtypes for PCR and Genbank data on HPV, we designed probes for the simultaneous detection of 18 high-risk subtypes (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 83 and MM4) and 5 low-risk subtypes (HPV-6, 11, 42, 43 and 44) and fixed them to the special membrane to make a DNA chip. A total of 112 male urethral samples were collected with swabs and studied for the clinical value. Meanwhile the single subtypes of HPV positive were sequenced and the standard samples detected for their sensitivity.
RESULTSOf the total number, 25 samples were found to be HPV positive, 13 single HPV infection and 12 multiple infection. Nine HPV gene subtypes were noted in the samples: 6, 11, 16, 18, 33, 35, 43, 56 and 73, with sensitivity up to 10 copies of HPV DNA.
CONCLUSIONHuman papillomavirus genotyping by the membrane DNA chip is applicable to the diagnosis of male HPV infection as well as to the related epidemic and etiological investigation.
Adult ; Aged ; Base Sequence ; DNA Probes, HPV ; genetics ; DNA, Viral ; genetics ; isolation & purification ; Genotype ; Humans ; In Situ Hybridization ; Male ; Middle Aged ; Molecular Sequence Data ; Papillomaviridae ; genetics ; isolation & purification ; Papillomavirus Infections ; diagnosis ; virology
5.The development and clinical application of papillomavirus genotyping by DNA chip.
Guang YANG ; Cai-hong LIANG ; Jin-huan CUI ; Shu CHEN
Chinese Journal of Epidemiology 2006;27(1):47-49
OBJECTIVETo develop a new platform for genotyping human papillomavirus (HPV) and to investigate its effect in clinical application.
METHODSA pair of common primers of 18 HPV subtypes for PCR, was designed in HPV conservative L1 region. Genotyping probes for detecting 15 high-risk HPV subtypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68, together with 3 low-risk HPV 6, 11 and 42 were selected respectively from Genbank and fixed on membrane to make DNA chip. PCR amplification and DNA chip technology were optimized. 100 clinical samples were used to investigate the effect of HPV genotyping DNA chip. Veracity of the genotyping results was verified by sequencing.
RESULTSFrom the 100 clinical samples, 30 were found to be HPV positive, including high-risk HPV subtypes 16, 18, 33, 45, 51, 58, and 66, and low-risk HPV 6, 11 and 42. The sensitivity tested by standard samples was up to 10 copies of HPV DNA.
CONCLUSIONThe HPV genotyping system developed here with DNA chip showed high sensitivity and specificity, suitable to be applied in clinical practice for HPV diagnosis and investigation on the prevalence of HPV sub-types.
DNA Probes, HPV ; genetics ; DNA, Viral ; genetics ; Female ; Genotype ; Humans ; Molecular Sequence Data ; Oligonucleotide Array Sequence Analysis ; methods ; Papillomaviridae ; classification ; genetics ; isolation & purification ; Papillomavirus Infections ; diagnosis ; virology ; Polymerase Chain Reaction ; Sensitivity and Specificity ; Uterine Cervical Neoplasms ; virology
6.Expression of CHOP in Squamous Tumor of the Uterine Cervix.
Hyun Hee CHU ; Jun Sang BAE ; Kyoung Min KIM ; Ho Sung PARK ; Dong Hyu CHO ; Kyu Yun JANG ; Woo Sung MOON ; Myoung Jae KANG ; Dong Geun LEE ; Myoung Ja CHUNG
Korean Journal of Pathology 2012;46(5):463-469
BACKGROUND: High-risk human papillomavirus (HR-HPV) infection and abnormal p53 expression are closely involved in carcinogenesis of squamous cell carcinoma (SqCC) of uterine cervix. Recent studies have suggested that virus-induced endoplasmic reticulum (ER) stress modulates various cell survival and cell death signaling pathways. The C/EBP homologous protein (CHOP) is associated with ER stress-mediated apoptosis and is also involved in carcinogenesis of several human cancers. We hypothesized that CHOP is involved in the carcinogenesis of uterine cervical cancer in association with HR-HPV and/or p53. METHODS: Immunohistochemistry was used to analyze CHOP and p53 protein expression of tissue sections from 191 patients with invasive cancer or preinvasive lesions of the uterine cervix (61 cases of SqCC, 66 cases of cervical intraepithelial neoplasia [CIN] III, and 64 cases of CIN I). RESULTS: CHOP was expressed in 59.4% of CIN I, 48.5% of CIN III, and 70.5% of SqCC cases. It was also significantly more frequent in invasive SqCC than in preinvasive lesions (p=0.042). Moreover, CHOP expression significantly correlated with HR-HPV infection and p53 expression (p=0.009 and p=0.038, respectively). CONCLUSIONS: Our results suggest that CHOP is involved in the carcinogenesis of the uterine cervix SqCC via association with HR-HPV and p53.
Apoptosis
;
Carcinoma, Squamous Cell
;
Cell Death
;
Cell Survival
;
Cervical Intraepithelial Neoplasia
;
Cervix Uteri
;
DNA Probes, HPV
;
Endoplasmic Reticulum
;
Female
;
Humans
;
Immunohistochemistry
;
Transcription Factor CHOP
;
Tumor Suppressor Protein p53
;
Uterine Cervical Neoplasms
7.Detecting HPV DNA in tissues of external genital squamous cell carcinoma in situ by PCR-RFLP technique.
Jia-bi WANG ; Xiao-hong MAN ; Yue-hua LIU ; Kai FANG
Acta Academiae Medicinae Sinicae 2003;25(6):667-670
OBJECTIVETo study the relationship between the infection of human papillomavirus (HPV) and external genital squamous cell carcinoma in situ.
METHODSHPV DNA was detected with the consensus primer by polymerase chain reaction (PCR) and its type was determined by restriction fragment length polymorphism (RFLP).
RESULTSHPV DNA was detected and HPV16 was the most frequently identified type in 29 (56.9%) of 51 cases of external genital squamous cell carcinoma in situ. HPV DNA was positive in 22 (55%) of 40 cases of bowenoid papulosis, among which 20 were of HPV16 type, one of HPV31 type, and one of HPV6 + 16 type. HPV DNA was positive in all 5 cases (100%) of Bowen's disease, among which 4 were HPV16 type and one of HPV6 + 16 type. HPV DNA was positive in 2 (33.3%) of 6 Queyrat erythroplasia cases and all were of HPV16 type.
CONCLUSIONHPV16 infection is strongly associated with the external genital squamous cell carcinoma in situ including bowenoid papulosis, Bowen's disease, and Queyrat erythroplasia.
Adult ; Aged ; Bowen's Disease ; virology ; Carcinoma in Situ ; virology ; Carcinoma, Squamous Cell ; virology ; DNA Probes, HPV ; DNA, Viral ; analysis ; Erythroplasia ; virology ; Female ; Genital Neoplasms, Female ; virology ; Genital Neoplasms, Male ; virology ; Humans ; Male ; Middle Aged ; Papillomaviridae ; isolation & purification ; Papillomavirus Infections ; virology ; Penile Neoplasms ; virology ; Polymorphism, Restriction Fragment Length ; Tumor Virus Infections ; virology ; Vulvar Neoplasms ; virology
8.Comparative analysis of abnormal thin-layer cytologic diagnosis, hybrid capture II HPV DNA testing results and histologic diagnosis in 2225 patients.
Ai-chun WANG ; Yi-qun GU ; Jun WANG ; Qiu-li ZHOU ; Li WANG ; Li-juan LU ; Hui ZHANG
Chinese Journal of Pathology 2011;40(1):46-47
Adult
;
Aged
;
Carcinoma, Squamous Cell
;
pathology
;
virology
;
Cervical Intraepithelial Neoplasia
;
pathology
;
virology
;
Colposcopy
;
Cytodiagnosis
;
DNA Probes, HPV
;
DNA, Viral
;
isolation & purification
;
Female
;
Humans
;
Middle Aged
;
Nucleic Acid Hybridization
;
Papillomaviridae
;
genetics
;
isolation & purification
;
Papillomavirus Infections
;
Uterine Cervical Neoplasms
;
pathology
;
virology
;
Vaginal Smears
;
Young Adult
9.Human Papillomavirus Prevalence and Genotype Distribution among HIV-Infected Women in Korea.
Eun Kyoung PARK ; Heerim CHO ; Sun Hee LEE ; Seung Geun LEE ; Sang Yeup LEE ; Ki Hyung KIM ; Chang Hun LEE ; Joo Seop CHUNG ; Ihm Soo KWAK
Journal of Korean Medical Science 2014;29(1):32-37
The epidemiology on human papillomavirus (HPV) among human immunodeficiency virus (HIV)-infected women in Korea is not well established. A retrospective study was conducted to determine the prevalence and genotype distribution of HPV infection among HIV-infected women in Korea. HPV DNA genotype and cervical cytology were examined in 60 HIV-positive women and 1,938 HIV-negative women. HPV genotypes were analyzed by using a HPV DNA chip. HIV-infected women had higher prevalence of high-risk HPV (hr-HPV) infection (30% vs 4.9%, adjusted odds ratio [AOR], 6.96; 95% confidence interval [CI], 3.63-13.34, P<0.001) and abnormal cervical cytology (18.3% vs 1.8%, AOR, 10.94; 95% CI, 5.18-23.1, P<0.001) compared with controls. The most common hr-HPV genotype detected in HIV-infected women was HPV 16 (10%), followed by 18 (6.7%) and 52 (5%). Prevalence of quadrivalent vaccine-preventable types (HPV 6, 11, 16, and 18) was 21.7% and 2.3% in HIV-positive women and HIV-negative women, respectively. Age was a significant risk factor for hr-HPV infection in HIV-infected women (P=0.039). The presence of hr-HPV was significantly associated with abnormal cervical cytology (P<0.001). These findings suggest that HPV testing for cervical cancer screening in HIV-infected women would be necessary, particularly among young age group.
Adult
;
Age Factors
;
Cervix Uteri/virology
;
DNA Probes, HPV/diagnostic use
;
DNA, Viral/genetics
;
Female
;
Genotype
;
HIV Infections/complications/*epidemiology/genetics
;
HIV-1/genetics
;
Human papillomavirus 11/genetics/isolation & purification
;
Human papillomavirus 16/genetics/isolation & purification
;
Human papillomavirus 18/genetics/isolation & purification
;
Human papillomavirus 6/genetics/isolation & purification
;
Humans
;
Middle Aged
;
Papillomavirus Infections/complications/*epidemiology/*genetics
;
Prevalence
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Uterine Cervical Neoplasms/epidemiology/genetics/virology